Dialyzed fetal bovine serum (FBS) is regular FBS that has been passed through a semi-permeable membrane to remove small molecules, typically anything below about 10,000 daltons. That stripping process pulls out amino acids, glucose, hormones, vitamins, nucleosides, and other low-molecular-weight metabolites while leaving behind the larger proteins and growth factors that cells need to survive. The practical difference matters enormously in the lab: regular FBS feeds your cells a complex, poorly defined cocktail of nutrients, while dialyzed FBS hands you a cleaner slate so you can control exactly which small molecules are present in the culture dish.
What Dialysis Actually Removes
Standard FBS is collected from bovine fetuses and contains thousands of components spanning a huge range of molecular sizes. Proteins like albumin, transferrin, and various growth factors are large enough to stay trapped on one side of a dialysis membrane. But the serum also carries a long list of smaller passengers: free amino acids such as serine and glutamine, energy substrates like glucose and pyruvate, nucleosides like hypoxanthine and inosine, lipid-associated small molecules, trace minerals, and steroid hormones. Dialysis against a saline or buffer solution lets those small molecules diffuse out through the membrane pores until equilibrium is reached, effectively washing them away.
The molecular weight cutoff of the dialysis membrane determines how thorough the separation is. Most commercial preparations use a cutoff somewhere around 10 kDa, though some go as low as 1 kDa or as high as 12–14 kDa. The result is serum that retains its protein content and macromolecular growth factors but has been largely emptied of the small-molecule pool. That makes it a fundamentally different supplement from regular FBS, even though both come from the same starting material.
Why Researchers Switch to Dialyzed FBS
The main reason to use dialyzed FBS is experimental control. If you want to study how cells respond to the removal of a specific amino acid, you cannot simply leave that amino acid out of your custom medium and call it a day. Regular FBS would smuggle it right back in, because the serum itself contains free amino acids at meaningful concentrations. Dialyzed FBS solves this by giving you a serum supplement that provides the growth factors cells need to stay alive without reintroducing the metabolites you are trying to manipulate.
This is why dialyzed FBS is essentially standard practice in nutrient-deprivation and metabolic-tracing experiments. Studies investigating how cells sense and respond to amino acid withdrawal routinely culture cells in media containing dialyzed rather than regular FBS.1Cell Reports. Amino acid sensing controls mitochondrial dynamics The same logic applies to glutamine-deprivation studies, where researchers need to ensure that the only source of glutamine is what they deliberately add.2Journal of Biological Chemistry. Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells Without dialyzed FBS, these kinds of starvation experiments are compromised because you cannot be sure the cells are truly starving.
Radioisotope and stable-isotope tracing experiments are another common application. When you feed cells a labeled nutrient to track its metabolic fate, any unlabeled version of that same nutrient floating in from regular FBS dilutes your signal and muddies the data. Dialyzed FBS keeps the background clean so the labeled molecules are the only ones the cells can use.
The Growth Problem
The trade-off is that removing all those small molecules can stunt cell growth, sometimes dramatically. Early work on human skin fibroblasts showed that cells plated at low densities grew very slowly or not at all in medium supplemented with 10% dialyzed FBS. Growth could be rescued by adding back just two metabolites: serine at 0.2 mM or pyruvate at 1.0 mM. With either supplement restored, the cells grew at rates comparable to those seen with regular, nondialyzed serum.3PubMed. Growth of human skin fibroblasts in dialyzed fetal bovine serum That finding highlights an important point: dialyzed FBS does not just remove the metabolite you care about. It removes everything small, and some of those removed molecules may be essential for normal cell behavior.
Endothelial cells tell a similar story. Porcine aortic endothelial cells stimulated with fibroblast growth factors proliferated much more slowly in dialyzed FBS than in regular FBS. The cells also changed shape, taking on a spindly morphology instead of their normal cobblestone-like appearance. Adding hypoxanthine, a purine nucleoside normally present in serum, restored both the growth rate and the typical cell shape.4Experimental Cell Research. Fibroblast growth factor-stimulated growth of porcine aortic endothelial cells depends on hypoxanthine in fetal bovine serum in culture media So the specific small molecule that matters varies by cell type. For fibroblasts it was serine or pyruvate; for endothelial cells it was hypoxanthine.
Work on salmon embryo cells showed a particularly stark contrast. DNA synthesis, measured by thymidine incorporation, was actually inhibited when cells were grown in dialyzed FBS or dialyzed calf serum alone. But adding just 10 µM inosine to the dialyzed serum boosted DNA synthesis by ten- to seventy-fold. In nondialyzed FBS, inosine had only a minor stimulatory effect, suggesting the intact serum already contained enough nucleosides to support baseline replication.5PubMed Central. Enhancement of proliferation in cultures of Chinook salmon embryo cells by interactions between inosine and bovine sera
The practical takeaway is that switching from regular FBS to dialyzed FBS is not a drop-in replacement. You often need to add back specific small molecules to support the cell type you are working with, keeping in mind which ones are acceptable for your experimental design and which would confound your results.
When Dialyzed FBS Changes Experimental Outcomes
Beyond slower growth, the switch can alter the biology you are trying to study in unexpected ways. A striking example comes from ferroptosis research. When researchers removed small molecules from FBS by dialysis and then subjected mouse embryonic fibroblasts to amino acid starvation, the dialyzed serum failed to trigger the potent cell death that regular FBS induced under the same conditions. In fact, dialyzed FBS appeared protective, presumably because the large proteins and growth factors that remain after dialysis promoted cell survival while the small pro-death metabolic factors had been washed away.6Molecular Cell. Regulation of Ferroptosis by Extracellular Metal-Containing and Metabolic Factors
This is a case where the choice of serum completely reversed the biological outcome. Researchers studying cell death pathways need to be aware that what they observe may depend on whether the small-molecule environment of the serum is intact. The iron and transferrin content of FBS, both of which survive dialysis, and the small metabolites that do not survive it appear to play distinct and sometimes opposing roles in determining whether a cell lives or dies under stress.
Dialyzed FBS Compared to Other Serum Treatments
Dialysis is not the only way to modify FBS before use. Each treatment strips out a different subset of components, and choosing the right one depends on what you are trying to control for.
Heat inactivation is the most common treatment and the most limited. Heating FBS to 56°C for 30 minutes destroys complement proteins and reduces some enzymatic activity, but it leaves the small-molecule content essentially untouched. Heat-inactivated FBS is not a substitute for dialyzed FBS if your goal is to control amino acids, nucleosides, or glucose.
Charcoal-dextran stripping takes a different approach. It uses activated charcoal coated with dextran to adsorb hydrophobic molecules, primarily steroid hormones like estrogen, progesterone, and testosterone. This makes charcoal-stripped FBS the go-to choice for hormone-responsive cell studies, such as estrogen-receptor research in breast cancer cell lines. A comparison in bovine embryo development showed that charcoal-dextran stripped FBS supported a higher blastocyst formation rate than heat-inactivated FBS, with roughly 43% versus 37% of embryos reaching the blastocyst stage. The embryos cultured in stripped serum also showed higher mitochondrial activity and lower intracellular lipid content.7PubMed Central. Effect of charcoal:dextran stripped fetal bovine serum on in vitro development of bovine embryos Charcoal stripping does not efficiently remove amino acids or small polar metabolites, though, so it cannot replace dialysis for nutrient-deprivation work.
Delipidation removes the lipid fraction from serum, including cholesterol, phospholipids, and fatty acids, while leaving proteins and small polar molecules behind. This is the treatment of choice when studying lipid metabolism or membrane biology. The lipid fraction turns out to be important for some applications in ways researchers do not always anticipate. In retroviral vector production, the absence of serum lipids was the main reason viral titers dropped. Adding cholesterol back to delipidated serum fully recovered productivity and actually pushed it above the levels seen with standard 10% FBS.8PubMed. Retroviral vector production under serum deprivation: The role of lipids
One way to think about the difference: dialysis is a size-based filter, charcoal stripping is a chemistry-based adsorbent targeting hydrophobic compounds, and delipidation specifically extracts fats. They can overlap, but they each have a distinct primary target. A researcher studying estrogen signaling would reach for charcoal-stripped serum, not dialyzed. A researcher running a glutamine tracing experiment would need dialyzed, not charcoal-stripped. Using the wrong treatment is a common source of experimental confusion.
Practical Tips for Working with Dialyzed FBS
If you are setting up experiments with dialyzed FBS for the first time, a few practical considerations can save you weeks of troubleshooting. The growth-rate reduction described earlier is real and can range from modest to severe depending on your cell type and plating density. Before committing to a full experiment, run pilot cultures comparing your cells in dialyzed versus regular FBS at the serum concentration and plating density you plan to use. Watch for changes in morphology, doubling time, and viability.
When growth drops unacceptably, the fix is usually targeted add-back of specific metabolites. The literature suggests that serine and pyruvate are common rescue molecules for fibroblasts,9PubMed. Growth of human skin fibroblasts in dialyzed fetal bovine serum while nucleosides like hypoxanthine and inosine support purine-dependent cell types.10Experimental Cell Research. Fibroblast growth factor-stimulated growth of porcine aortic endothelial cells depends on hypoxanthine in fetal bovine serum in culture media The key is to add back only what your cells need to survive without reintroducing whatever you are trying to deplete. If you are starving cells of glutamine, adding pyruvate as a growth rescue is fine. Adding a full amino acid supplement would defeat the purpose.
Serum concentration matters more than you might expect. The same early fibroblast study found that at high concentrations of dialyzed serum, cells grew well and did not show the toxicity associated with high concentrations of regular FBS.11PubMed. Growth of human skin fibroblasts in dialyzed fetal bovine serum This makes intuitive sense: nondialyzed FBS at high concentrations floods cells with excess small molecules that can be inhibitory or toxic, while dialyzed FBS at the same protein concentration lacks those potentially problematic compounds. For some applications, increasing the percentage of dialyzed FBS rather than adding metabolites back may be the simpler solution.
Lot-to-lot variability is another concern. FBS composition varies between animals and between production batches, and dialysis does not eliminate that variability for the macromolecular fraction. Growth factor concentrations, transferrin levels, and residual endotoxin can all differ between lots. If your experiment is sensitive to serum components that survive dialysis, lot-testing remains just as important for dialyzed FBS as for regular FBS.
Common Misconceptions
One widespread misunderstanding is that dialyzed FBS is “serum-free” or somehow comparable to chemically defined media. It is not. Dialyzed FBS still contains hundreds of proteins and other macromolecules that are poorly characterized and variable between lots. If you need a fully defined culture environment, you need an actual serum-free formulation, not dialyzed serum.
Another misconception is that dialysis removes lipids. Most lipids in serum are bound to carrier proteins like albumin and lipoproteins, which are far above the dialysis molecular weight cutoff. So cholesterol, most fatty acids, and phospholipids largely remain in dialyzed FBS. Research on fibroblast fatty acid composition found that cells maintained in either delipidized or regular FBS showed similar stability of their cholesterol and phospholipid content, confirming that these lipid classes remain associated with the protein fraction and are available to cells even when the free small-molecule pool has been altered.12PubMed. Retention of human skin fibroblast fatty acid modifications during maintenance culture If lipid removal is your goal, you need delipidated serum, not dialyzed.
A third mistake is assuming that dialyzed FBS removes hormones. Small peptide hormones like insulin (about 5.8 kDa) may be partially removed depending on the membrane cutoff, but larger protein hormones and steroid hormones bound to carrier proteins often survive dialysis. For rigorous hormone-deprivation work, charcoal-dextran stripping is the established method.
Choosing Between Regular and Dialyzed FBS
The decision often comes down to whether your experiment depends on controlling the small-molecule environment. For routine cell maintenance, expansion, and assays that are not sensitive to the metabolite content of the medium, regular FBS is simpler and supports more robust growth. There is no benefit to using dialyzed FBS for everyday culture unless you have a specific reason.
Dialyzed FBS becomes necessary when your experimental readout can be confounded by unknown quantities of amino acids, sugars, nucleosides, or other small metabolites arriving via the serum. The most common scenarios include nutrient starvation or deprivation studies, isotope-labeling experiments, drug screens where serum metabolites could interact with the compound being tested, and assays measuring cellular uptake or secretion of small molecules. In all these cases, the uncontrolled small-molecule input from regular FBS introduces noise that can obscure or distort your results.
Cost is worth mentioning. Dialyzed FBS typically runs two to three times the price of regular FBS per bottle, and it has a shorter shelf life once thawed because some of the stabilizing small molecules have been removed. For labs that use large volumes, this can add up.
The Lipid Question in Viral Vector Production
One area where the distinction between different serum treatments has practical consequences beyond basic research is in the production of viral vectors for gene therapy. Viral particles need membrane components, particularly cholesterol, to assemble properly. When cells producing retroviral vectors were grown in serum-reduced conditions, vector titers dropped significantly, and the cause was traced specifically to the absence of serum lipids. Supplementing the medium with cholesterol alone was enough to fully recover titers, and in some cases viral output exceeded what was achieved with standard 10% FBS.13PubMed. Retroviral vector production under serum deprivation: The role of lipids
This finding matters for anyone working with dialyzed FBS in a viral production context. Because dialysis largely preserves the protein-bound lipid fraction, it may be less disruptive to viral packaging than full serum reduction or delipidation. But the exact impact depends on how much free cholesterol and other membrane precursors are lost during the dialysis process, which varies with the membrane cutoff and dialysis conditions. Checking viral titers after switching to dialyzed FBS is worth doing before committing to a production run.
Cell-Type Differences That Catch People Off Guard
Perhaps the most frustrating aspect of working with dialyzed FBS is that the effects are not universal. Some cell lines barely notice the switch; others stall completely. The underlying reason is that different cell types have different capacities for synthesizing the small molecules that dialysis removes. A cell line that can make its own serine from glycolytic intermediates will handle dialyzed FBS just fine. A cell line that depends on exogenous serine will struggle. The same principle applies to nucleotide biosynthesis: cells with active de novo purine and pyrimidine synthesis pathways are less affected by the loss of serum nucleosides than cells that rely heavily on the salvage pathway.
Cancer cell lines are a particular area of variation. Many tumors rewire their metabolism in ways that create dependencies on specific nutrients. A cancer line that is addicted to exogenous glutamine, for instance, may behave very differently in dialyzed versus regular FBS, even before you deliberately remove glutamine, because the baseline amino acid supply from the serum is already gone. This metabolic diversity is actually one reason dialyzed FBS is so valuable in cancer research: it exposes dependencies that regular FBS would mask. But it also means you cannot assume that a protocol optimized for one cell line will transfer cleanly to another.
Primary cells and stem cells tend to be more sensitive to dialyzed FBS than established cell lines, which have typically adapted to culture conditions over many passages. If you are working with freshly isolated cells or early-passage cultures, plan for a more gradual transition and more extensive optimization of add-back supplements.